Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 3
2005 3
2006 2
2007 1
2008 1
2009 2
2010 1
2011 11
2012 6
2013 7
2014 4
2015 7
2016 7
2017 9
2018 5
2019 10
2020 13
2021 11
2022 12
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Große Fortschritte dank neuer Substanzen.
Klinker H. Klinker H. MMW Fortschr Med. 2015 Jun;157 Suppl 2:36-40. doi: 10.1007/s15006-015-3165-4. MMW Fortschr Med. 2015. PMID: 26048119 Review. German. No abstract available.
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.
Dietz J, Müllhaupt B, Buggisch P, Graf C, Peiffer KH, Matschenz K, Schattenberg JM, Antoni C, Mauss S, Niederau C, Discher T, Trauth J, Dultz G, Schulze Zur Wiesch J, Piecha F, Klinker H, Müller T, Berg T, Neumann-Haefelin C, Berg CP, Zeuzem S, Sarrazin C; German HCV Resistance Study Group; University Hospitals; Academic Hospitals; Local study sites (private practices), Germany. Dietz J, et al. Among authors: klinker h. J Hepatol. 2023 Jan;78(1):57-66. doi: 10.1016/j.jhep.2022.08.016. Epub 2022 Aug 27. J Hepatol. 2023. PMID: 36031158
Clinical management of drug-drug interactions in HCV therapy: challenges and solutions.
Burger D, Back D, Buggisch P, Buti M, Craxí A, Foster G, Klinker H, Larrey D, Nikitin I, Pol S, Puoti M, Romero-Gómez M, Wedemeyer H, Zeuzem S. Burger D, et al. Among authors: klinker h. J Hepatol. 2013 Apr;58(4):792-800. doi: 10.1016/j.jhep.2012.10.027. Epub 2012 Nov 5. J Hepatol. 2013. PMID: 23137766 Free article. Review.
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries.
Hou JL, Zhao W, Lee C, Hann HW, Peng CY, Tanwandee T, Morozov V, Klinker H, Sollano JD, Streinu-Cercel A, Cheinquer H, Xie Q, Wang YM, Wei L, Jia JD, Gong G, Han KH, Cao W, Cheng M, Tang X, Tan D, Ren H, Duan Z, Tang H, Gao Z, Chen S, Lin S, Sheng J, Chen C, Shang J, Han T, Ji Y, Niu J, Sun J, Chen Y, Cooney EL, Lim SG. Hou JL, et al. Among authors: klinker h. Clin Gastroenterol Hepatol. 2020 Feb;18(2):457-467.e21. doi: 10.1016/j.cgh.2019.07.010. Epub 2019 Jul 12. Clin Gastroenterol Hepatol. 2020. PMID: 31306800 Clinical Trial.
Linguatuliasis in Germany.
Tappe D, Winzer R, Büttner DW, Ströbel P, Stich A, Klinker H, Frosch M. Tappe D, et al. Among authors: klinker h. Emerg Infect Dis. 2006 Jun;12(6):1034-6. doi: 10.3201/eid1206.051413. Emerg Infect Dis. 2006. PMID: 16752476 Free PMC article. No abstract available.
[Development and validation of potential structure indicators for clinical infectious disease (ID) care in German hospitals during the COVID-19 pandemic].
Tscharntke L, Stecher M, Classen AY, Jung N, Eberwein L, Friedrichs A, Klinker H, Schons MJ, Spinner CD, J G T Vehreschild M, de With K, Vehreschild JJ. Tscharntke L, et al. Among authors: klinker h. Z Evid Fortbild Qual Gesundhwes. 2023 Feb;176:12-21. doi: 10.1016/j.zefq.2022.11.005. Epub 2023 Feb 6. Z Evid Fortbild Qual Gesundhwes. 2023. PMID: 36754716 Free PMC article. Review. German.
104 results